$53.00
-1.40-2.57%
Pre-Market: 4:58 AM EDT
Comments
Loading...
MoonLake (MLTX) Forecast
NewsEarningsMoonLake (MLTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMoonLake (NASDAQ:MLTX) Stock Quotes, Forecast and News Summary
MoonLake Stock (NASDAQ: MLTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy MoonLake (MLTX) stock?
You can purchase shares of MoonLake (NASDAQ:MLTX) through any online brokerage.
Who are MoonLake (MLTX) competitors?
Other companies in MoonLake’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and SpringWorks Therapeutics (NASDAQ:SWTX).
What is the forecast, or price target, for MoonLake (MLTX) stock?
MoonLake has a consensus price target of $64.54.
What is the current price for MoonLake (MLTX)?
The stock price for MoonLake (NASDAQ: MLTX) is $53 last updated December 27, 2024 at 4:58 AM EST.
Does MoonLake (MLTX) pay a dividend?
There are no upcoming dividends for MoonLake.
When is MoonLake (NASDAQ:MLTX) reporting earnings?
MoonLake’s Q4 earnings are confirmed for Thursday, February 27, 2025.
Is MoonLake (MLTX) going to split?
There is no upcoming split for MoonLake.
What sector and industry does MoonLake (MLTX) operate in?
MoonLake is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.